Pier Giorgio Cojutti

19PUBLICATIONS
21CO-AUTHORS
Medical bacteriologyHaematological tumoursInfant and child healthPharmacogenomicsBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 03, 2026
Relationship between continuous infusion meropenem PK/PD target attainment and C-reactive protein dynamics in onco-haematologic patients with febrile neutropenia.

|Jun 03, 2026
Likelihood of aggressive PK/PD target attainment of continuous-infusion beta-lactams during the first week of treatment of febrile neutropenia: findings from a 1-year prospective, monocentric study in onco-haematological patients.

|Nov 23, 2025
Can a population pharmacokinetics model built on intermittent infusions accurately predict meropenem concentrations in children receiving continuous infusions?

Lucy Cheng, Suchita Kumar, Pier Giorgio Cojutti

|Nov 03, 2025
Population Pharmacokinetics of a Novel Oral Fosfomycin Prophylactic Scheme in the Plasma and Prostate of Patients Undergoing Endoscopic Surgery for Benign Prostatic Hyperplasia.

Pier Giorgio Cojutti, Pasquale Maria Berrino, Valeria Rotaru

|Oct 29, 2025
Keeping the horse with the cart: are we underdosing tazobactam even when using continuous-infusion ceftolozane/tazobactam for effectively preventing resistance development by ESBL-producing Enterobacterales?

Manjunath P Pai, Pier Giorgio Cojutti, Milo Gatti

|Sep 22, 2025
Targeting Pseudomonas aeruginosa resistance at the exposure frontier: a population PK/PD blueprint for ceftolozane/tazobactam continuous infusion.

Pier Giorgio Cojutti, Manjunath P Pai, Milo Gatti

Pageof 4

Frequent Collaborators

13 joint publications

Federico Pea

5 joint publications

Milo Gatti

1 joint publications

Anna Candoni

1 joint publications

Davide Lazzarotto